Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2005
11/10/2005US20050250698 Method for obtaining a TGF-beta enriched protein fraction in activated form, protein fraction and therapeutic applications
11/10/2005US20050250697 Method for obtaining a TGF-beta enriched protein fraction in activated form, protein fraction and therapeutic applications
11/10/2005US20050250696 Truncated soluble tumor necrosis factor type-I and type-II receptors
11/10/2005US20050250695 Combination PDGF, KGF, IGF, and IGFBP for wound healing
11/10/2005US20050250693 Metalloproteinase inhibitors
11/10/2005US20050250690 Leptin peptide antagonists
11/10/2005US20050250689 Antagonists for human prolactin
11/10/2005US20050250687 Anti-tumor activity of Ea-4-peptide of pro-IGF-I
11/10/2005US20050250685 Peptides with wound healing activity
11/10/2005US20050250684 Method for reducing morbidity and mortality in critically ill patients
11/10/2005US20050250680 Treating leukemia by administering a cross-linked polypeptide antiapoptosis agent having at least two modified amino acids ("hydrocarbon stapling"); crosslinking increases cell permeability
11/10/2005US20050250678 polypeptide (interferon, colony stimulating factor, human growth hormone) having an O-linked glycosylation site that does not exist in a wild type polypeptide; glycoconjugates in which a species such as a water-soluble polymer, a therapeutic agent or a biomolecule is covalently linked through the site
11/10/2005US20050250206 Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes
11/10/2005US20050250185 OGH fusion polypeptides and therapeutic uses thereof
11/10/2005US20050250184 Peptide hormones zalpha48 and zsig97
11/10/2005US20050250183 In vivo incorporation of unnatural amino acids
11/10/2005US20050250182 Novel genes, compositions, and methods for modulating the unfolded protein response
11/10/2005US20050250180 Secreted protein and polynucleotides encoding them
11/10/2005US20050250178 WNT-regulated cytokine-like polypeptide and nucleic acids encoding same
11/10/2005US20050250153 Novel fetal genes
11/10/2005US20050250150 outer membrane proteins (OMPs) that, alone or in combination, are capable of inducing protective immunity against Lawsonia intracellularis bacteria
11/10/2005US20050250149 Proteinase inhibitor, precursor thereof and genetic sequences encoding same
11/10/2005US20050250144 Novel genes encoding protein kinase/protein phosphatase
11/10/2005US20050250143 MEKK1-interacting FHA protein 1 (MIF1)
11/10/2005US20050250136 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/10/2005US20050250135 Nucleic acid encoding a polypeptide having histidine kinase activity; plasmids and host cells; engineering microorganisms, including Lactobacillus acidophilus, to have an increased ability to tolerate various stress conditions; probiotics
11/10/2005US20050250131 Methods for obtaining thermostable enzymes, DNA polymerase I variants from Thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications of the same
11/10/2005US20050250128 Membranes incorporating recognition moieties
11/10/2005US20050250127 Methods for identifying modulators of MDA-7 mediated apoptosis
11/10/2005US20050250126 Ztnf13, a tumor necrosis factor
11/10/2005US20050250120 Deleted sequences in M. bovis BCG/M bovis or M. tuberculosis, method for detecting mycobacteria using these sequences and vaccines
11/10/2005US20050250110 PNA conjugate for treating chronic myeloid leukemia (CML)
11/10/2005US20050250104 Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a bac-based DNA library. application to the detection of mycobacteria
11/10/2005US20050250102 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1
11/10/2005US20050250093 Hepatitis c virus sub-genomic replicons
11/10/2005US20050249828 Canola protein isolate compositions
11/10/2005US20050249815 Process for producing a plasma protein-containing medicament
11/10/2005US20050249786 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
11/10/2005US20050249754 CD4+ T-lymphocyte-specific hepatitis C virus epitopes
11/10/2005US20050249752 Vector for anti-hpv vaccine and transformed microorganism by the vector
11/10/2005US20050249750 Universal T-cell epitopes for anti-malarial vaccines
11/10/2005US20050249748 Polypeptides; antigens; vaccines; fusion protein containing signal peptide and polypeptide; genetic engineered Listeria bacteria
11/10/2005US20050249747 Recombinant high molecular weight major outer membrane protein of Moraxella
11/10/2005US20050249746 useful in inducing a protective immune response against NTHi in an immunized human
11/10/2005US20050249745 Papilloma virus truncated L1 protein and fusion protein constructs
11/10/2005US20050249744 Mhc class II haplotype specific immunodominancy of peptides derived from rsv fusion (f) and attachement (g) proteins
11/10/2005US20050249743 Isolated peptides which bind to HLA-A24 molecules and uses thereof
11/10/2005US20050249742 Compositions and methods for modulating a cytotoxic T lymphocyte immune response
11/10/2005US20050249741 Novel Semaphorin gene: Semaphorin W
11/10/2005US20050249738 Immunotoxins directed against malignant cells
11/10/2005US20050249737 Dendritic cell potentiation
11/10/2005US20050249734 Cortistatin: neuropeptides, compositions and methods
11/10/2005US20050249727 Prevention and treatment of amyloidogenic disease
11/10/2005US20050249725 Improving cognitive function of individuals with beta amyloid disfunction utilizing beta amyloid specific immunoglobulin; immunotherapeutics
11/10/2005US20050249711 Allogeneic vaccine and methods to synthesize same
11/10/2005US20050249705 Inactivated herpes simplex virus glycoprotein for treating metastasis; ultraviolet radiation and heating; highly safe
11/10/2005US20050249703 A polynucleotide encoding a carboxy-truncated interferon gamma (IFNG) polypeptide mutant exhibiting IFNG receptor binding activity having the amino acid sequence, SEQ ID NO:12, or 1-10 residue modifications; antitumor, -carcinogenic agent; viricides; interstitial lung diseases; autoimmune diseases
11/10/2005US20050249701 Il-7 Drug substance, composition, preparation and uses
11/10/2005US20050249700 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
11/10/2005US20050249698 Synergistic effect of the osteogenic growth peptide and the granulocyte clony stimulating factor on haematogenesis
11/10/2005US20050249682 Durability, efficiency, bind with high affinity to hair, skin, and nails
11/10/2005US20050249671 Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof
11/10/2005US20050249668 Nir-fluorescent cyanine dyes, their synthesis and biological use
11/10/2005DE202004020676U1 Storage-stable liquid erythropoietin formulation, for treatment of renal insufficiency, comprises specified amino acids but no preservatives, urea or albumen and is not a reconstituted lyophilizate
11/10/2005DE10347710A1 Rekombinante Impfstoffe und deren Verwendung Recombinant vaccines and their use
11/10/2005DE102004019803A1 Process to purify a soluble MHC protein in which the recombined product is soluble and not truncated
11/10/2005DE102004018608A1 Doppelt transfizierte Zellinien als in-vitro-Screening-Werkzeuge zur Erstellung von Profilen pharmazeutischer Verbindungen:Ein Modell für die hepatobiläre Elimination Double-transfected cell lines as in vitro screening tools for creating profiles pharmaceutical compounds: A model for the hepatobiliary elimination
11/10/2005DE102004018418A1 Diagnose entzündlicher Darmerkrankungen, insbesondere Colitis ulcerosa Diagnosis of inflammatory bowel diseases, particularly ulcerative colitis
11/10/2005CA2607113A1 Interleukin-1 receptor antagonists, compositions, and methods of treatment
11/10/2005CA2607015A1 Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same
11/10/2005CA2564968A1 Modulation of cartilage homeostasis
11/10/2005CA2564807A1 Methods and materials for improving plant drought tolerance
11/10/2005CA2564525A1 Ion channel
11/10/2005CA2564179A1 Biologically active peptide vapeehptllteaplnpk derivatives
11/10/2005CA2564177A1 Caspase-2 inhibitors and their biological applications
11/10/2005CA2564150A1 Essential tremor diagnostic and treatment
11/10/2005CA2564131A1 Novel therapeutic targets in cancer
11/10/2005CA2562181A1 A protein involved in cancer
11/10/2005CA2559809A1 Antibodies against human g-protein chemokine receptor (ccr5) hdgnr10
11/09/2005EP1593740A1 Method of screening anti-obestic medicine, and obesity model animal
11/09/2005EP1593738A1 Virus-like particle vaccine containing dengue virus recombinant replicon as its carrier
11/09/2005EP1593737A1 Use of the ACA glycoprotein for obtaining/maintaining pluripotent non-embryonic stem cells
11/09/2005EP1593689A2 Myostatin and mimetics thereof
11/09/2005EP1593688A1 Method for partition and inactivation of viral and prion contaminants
11/09/2005EP1593687A2 Human genes differentially expressed in colon cancer
11/09/2005EP1593387A1 Compositions for the treatment of impaired interpersonal and behavioral disorders
11/09/2005EP1593384A2 Compositions for treatment of sexual dysfunction
11/09/2005EP1592808A2 Single nucleotide polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy
11/09/2005EP1592801A2 Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites
11/09/2005EP1592800A2 Mesecnhymal stem cells as a vehicle for ion channel transfer in syncytial structures
11/09/2005EP1592796A2 Helminth-derived antigens having capacity of providing protection against parasites
11/09/2005EP1592789A2 Administration of transposon-based vectors to reproductive organs
11/09/2005EP1592784A1 Method for the genetic modification of organisms of the genus blakeslea, corresponding organisms, and the use of the same
11/09/2005EP1592780A2 Dyrks as modifiers of the apc and axin pathways and methods of use
11/09/2005EP1592710A2 Macaque alpha-7 nicotinic acetylcholine receptor and methods of use thereof
11/09/2005EP1592709A2 Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions
11/09/2005EP1592708A2 Therapeutic gpcr targets in cancer
11/09/2005EP1592707A2 Hmgb1 modulator binding domain
11/09/2005EP1592706A2 Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy
11/09/2005EP1592703A1 Method for protein isolation in anoxic conditions
1 ... 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 ... 2916